Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BDKRB2 known ✓ | P30411 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 4/20 | 0.50 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | FDPS | P14324 | 1/20 | 0.31 |
| ▸ | CTSS | P25774 | 1/20 | 0.30 |
| ▸ | CTSK | P43235 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31447339 | 0.97 | TSHR (0.52) | TSHRDNM1BDKRB2ALDH1A1TDP1 | |
| Iodide SCHEMBL3780208 | 0.95 | TSHR (0.50) | TSHRDNM1BDKRB2ALDH1A1TDP1 | |
| Fluoride Ion SCHEMBL18244889 | 0.92 | TSHR (0.48) | TSHRDNM1BDKRB2ALDH1A1TDP1 | |
| Hydrochloric Acid SCHEMBL11236841 | 0.80 | TSHR (0.59) | TSHRDNM1BDKRB2ALDH1A1TDP1 | |
| Hydrochloric Acid SCHEMBL23198627 | 0.76 | DNM1 (0.75) | TSHRDNM1BDKRB2ALDH1A1TDP1 | |
| Hydrochloric Acid SCHEMBL124627 | 0.76 | DNM1 (0.75) | TSHRDNM1BDKRB2ALDH1A1TDP1 | |
| Cyanate SCHEMBL10909220 | 0.76 | DNM1 (0.57) | TSHRDNM1BDKRB2ALDH1A1TDP1 | |
| Acetonitrile SCHEMBL28136456 | 0.76 | DNM1 (0.62) | TSHRDNM1BDKRB2ALDH1A1TDP1 | |
| Thiocyanic Acid SCHEMBL31021419 | 0.76 | DNM1 (0.57) | TSHRDNM1BDKRB2ALDH1A1TDP1 | |
| Hydrochloric Acid SCHEMBL4273266 | 0.74 | DNM1 (0.71) | TSHRDNM1BDKRB2ALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122037022-A | Method for preparing high-strength adhesive by catalyzing aminated polyvinyl chloride | 华东理工大学 | 2026-05-15 | — | — | CN | claimed |
| WO-2023159094-A2 | PROCESS OF MAKING 3α-HYDROXY-3β-METHOXYMETHYL-21-(1'- IMIDAZOLYL)-5α-PREGNAN-20-ONE | PRAXIS PRECISION MEDICINES, INC. (US) | 2023-08-24 | — | — | WO | claimed |
| US-20220127238-A1 | PROCESS FOR THE PREPARATION OF ANGIOTENSIN II RECEPTOR BLOCKERS | HETERO LABS LIMITED (IN) | 2022-04-28 | — | — | US | claimed |
| CN-122037022-A | Method for preparing high-strength adhesive by catalyzing aminated polyvinyl chloride | 华东理工大学 | 2026-05-15 | — | — | CN | disclosed |
| WO-2026087965-A1 | COMPOSITION COMPRISING EPOXY RESIN WITH CONSTRAINED AROMATIC RINGS AND PHOTOBASE | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2026-04-30 | — | — | WO | disclosed |
| US-12459181-B2 | Layered body and extrusion-molded article | DAIKIN INDUSTRIES, LTD. (JP) | 2025-11-04 | — | — | US | disclosed |
| EP-4640688-A1 | AVERMECTIN DERIVATIVE | Meiji Seika Pharma Co., Ltd. (JP) | 2025-10-29 | — | — | EP | disclosed |
| US-12454087-B2 | Layered body and extrusion-molded article | DAIKIN INDUSTRIES, LTD. (JP) | 2025-10-28 | — | — | US | disclosed |
| WO-2025200154-A1 | TWO-PART EPOXY COMPOSITION COMPRISING THIOL CURATIVE, AND CATALYST | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2025-10-02 | — | — | WO | disclosed |
| US-20250261553-A1 | NOVEL COMPOUND, CONJUGATED POLYMER AND METHOD FOR PRODUCING SAME, FILM FORMATION COMPOSITION, ORGANIC THIN FILM AND ORGANIC SEMICONDUCTOR ELEMENT | TOSOH CORPORATION (JP) | 2025-08-14 | — | — | US | disclosed |
| EP-4516794-A1 | NOVEL COMPOUND, CONJUGATED POLYMER AND METHOD FOR PRODUCING SAME, FILM FORMATION COMPOSITION, ORGANIC THIN FILM, AND ORGANIC SEMICONDUCTOR ELEMENT | Tosoh Corporation (JP) | 2025-03-05 | — | — | EP | disclosed |
| US-8816138-B2 | Method for producing 3-chloro-pentafluoropropene | DAIKIN INDUSTRIES, LTD. (JP) | 2014-08-26 | — | — | US | disclosed |
| EP-2674395-A1 | PROCESS FOR PRODUCTION OF FLUOROSULFONYLIMIDE AMMONIUM SALT | Nippon Soda Co., Ltd. (JP) | 2013-12-18 | — | — | EP | disclosed |
| US-20130331609-A1 | PRODUCTION PROCESS FOR FLUOROSULFONYLIMIDE AMMONIUM SALT | NIPPON SODA CO., LTD. (JP) | 2013-12-12 | — | — | US | disclosed |
| US-20130323154-A1 | PROCESS FOR PRODUCTION OF FLUOROSULFONYLIMIDE AMMONIUM SALT | NIPPON SODA CO., LTD. (JP) | 2013-12-05 | — | — | US | disclosed |
| EP-2660196-A1 | MANUFACTURING METHOD FOR FLUOROSULFONYLIMIDE AMMONIUM SALT | Nippon Soda Co., Ltd. (JP) | 2013-11-06 | — | — | EP | disclosed |
| EP-2554530-A1 | METHOD FOR PRODUCING 3-CHLORO-PENTAFLUOROPROPENE | Daikin Industries, Ltd. (JP) | 2013-02-06 | — | — | EP | disclosed |
| US-20130023704-A1 | METHOD FOR PRODUCING 3-CHLORO-PENTAFLUOROPROPENE | DAIKIN INDUSTRIES, LTD. (JP) | 2013-01-24 | — | — | US | disclosed |
| US-7273953-B2 | Process for producing arylamine | FUJIFILM FINECHEMICALS CO., LTD. (JP) | 2007-09-25 | — | — | US | disclosed |
| US-20060069287-A1 | Process for producing arylamine | FUJIFILM FINECHEMICALS CO., LTD. (JP) | 2006-03-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130331609-A1 | PRODUCTION PROCESS FOR FLUOROSULFONYLIMIDE AMMONIUM SALT | NPEPPS, DNPEP, FOS | BDKRB2 4754/4885TSHR 3929/4885DNM1 680/4885 |
| US-20060069287-A1 | Process for producing arylamine | TYR, AADAC, AOC2 | BDKRB2 551/4885TSHR 605/4885DNM1 2667/4885 |
| US-20130323154-A1 | PROCESS FOR PRODUCTION OF FLUOROSULFONYLIMIDE AMMONIUM SALT | ASNS, NHERF1, NAAA | BDKRB2 4617/4885TSHR 2805/4885DNM1 282/4885 |
| US-20220127238-A1 | PROCESS FOR THE PREPARATION OF ANGIOTENSIN II RECEPTOR BLOCKERS | AGTR2, AGTR1, ADRB1 | BDKRB2 36/4885TSHR 199/4885DNM1 2968/4885 |
| US-20250261553-A1 | NOVEL COMPOUND, CONJUGATED POLYMER AND METHOD FOR PRODUCING SAME, FILM FORMATION COMPOSITION, ORGANIC THIN FILM AND ORGANIC SEMICONDUCTOR ELEMENT | CD99, SOAT2, SOAT1 | BDKRB2 4717/4885TSHR 4672/4885DNM1 2884/4885 |
| US-20130023704-A1 | METHOD FOR PRODUCING 3-CHLORO-PENTAFLUOROPROPENE | PFAS, FFAR3, NOTUM | BDKRB2 3618/4885TSHR 238/4885DNM1 1637/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.